Our News
The 300-patient study is designed for optimizing Cellsway’s CTC enrichment, identification and characterization workflow with clinical samples. The patients for the study are being selected from newly diagnosed Stage III/IV …
You can reach the whole interview in English and in Turkish.
From a career of over 35 years, Elaine brings a broad knowledge of innovation pathways across therapeutics and healthcare technologies, a strong background in marketing and an extensive network. Elaine’s …
M.D. Prof. Hüseyin Baloğlu was graduated from GATA Medical School (Ankara, Turkey) in 1986 and had his specialty education at GATA Medical School Pathology Department in 1992. He was at …
Dr. O’Shannessy has more than 20 years’ Executive Management experience in the fields of translational/precision medicine and diagnostics, specifically in oncology…
From over 5000 applications, our company has been named as one of six ‘Digital Health & Medical Devices’ finalist. Come and…
Cellsway has received Advanced Assurance for the Enterprise Investment Scheme (EIS)…
We are very proud to announce that Cellsway has been selected to the Global Entrepreneur Programme (GEP), an official support programme of the UK Department for International Trade (DIT). Through …
